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Abstract  Community-acquired  methicillin-resistant  Staphylococcus  aureus  is  the  ﬁrst  cause
of skin  and  soft  tissue  infections,  but  can  also  produce  severe  diseases  such  as  bacteremia,
osteomyelitis  and  necrotizing  pneumonia.  Some  S.  aureus  lineages  have  been  described  in  cases
of necrotizing  pneumonia  worldwide,  usually  in  young,  previously  healthy  patients.  In  this  work,
we describe  a  fatal  case  of  necrotizing  pneumonia  due  to  community-acquired  methicillin-
resistant  S.  aureus  clone  ST30-SCCmecIVc-spat019-PVL  positive  in  an  immunocompetent  adult
patient.
© 2014  Asociación  Argentina  de  Microbiología.  Published  by  Elsevier  España,
S.L.U. This  is  an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
PALABRAS  CLAVE
Neumonía
Neumonía  necrotizante  adquirida  en  la  comunidad  causada  por  Staphylococcus
aureus  resistente  a  meticilina  ST30-SCCmecIVc-spat019-LPV  positivo  en  San  Antonionecrotizante; de  Areco,  Argentina
 aureus  resistente  a  meticilina  adquirido  en  la  comunidad  es  la
es  de  piel  y  partes  blandas,  aunque  también  puede  producir  infec-
riemia,  osteomielitis  y  neumonía  necrotizante.  Algunos  linajes  deStaphylococcus
aureus  resistente  a
meticilina  adquirido
en la  comunidad;
Resumen  Staphylococcus
primera causa  de  infeccion
ciones graves,  como  bacteST30 S. aureus  se  han  asociado  a  casos  de  neumonía  necrotizante  en  el  mundo,  generalmente  en
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Necrotizing  pneumonia  due  to  CA-MRSA  ST30-SCCmecIVc-PVL  positive  51
pacientes  jóvenes  previamente  sanos.  En  este  trabajo  comunicamos  un  caso  fatal  de  neumonía
necrotizante  causado  por  el  clon  de  S.  aureus  resistente  a  meticilina  adquirido  en  la  comunidad
ST30-SCCmecIVc-spat019-LPV  positivo,  en  un  paciente  adulto  inmunocompetente.
© 2014  Asociación  Argentina  de  Microbiología.  Publicado  por  Elsevier  España,
S.L.U. Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
g
4
9
p
r
t
(
i
t
c
p
o
r
6
%
b
s
l
a
m
a
E
ﬁ
(
S
t
s
a
p
i
h
i
a
t
b
a
c
p
aMost  commonly,  community-acquired  methicillin-
resistant  Staphylococcus  aureus  (CA-MRSA)  produces  skin
and  soft-tissue  infections  while  severe  and  life-threatening
infections  such  as  meningitis,  necrotizing  pneumonia,  and
severe  sepsis  are  rare.  CA-MRSA  strains  are  globally  spread;
however,  the  prevalence  and  clonal  distribution  is  dynamic.
Unlike  hospital-acquired  MRSA  (HA-MRSA),  CA-MRSA
strains  usually  carry  SCCmec type  IV,  produce  Panton-
Valentine  leukocidin  (PVL)  and  show  susceptibility  to  several
non-ß-lactam  antibiotics13.
Necrotizing  pneumonia  (NP)  is  a  severe  form  of  lung
disease  associated  with  the  formation  of  abscesses  and
cavitation  within  the  lung  parenchyma.  This  syndrome  is
characterized  by  respiratory  insufﬁciency  and  rapid  devel-
opment  of  septic  shock,  in  the  context  of  fever,  hemoptysis,
leukopenia,  multilobar  necrosis,  cavitary  lesions  and  pleu-
ral  effusion,  and  it  is  associated  with  a  high  mortality
rate14.
Among  the  several  virulence  factors  related  to  CA-MRSA,
Panton-Valentine  leukocidin  is  a  bicomponent  toxin  that  kills
leukocytes  by  creating  pores  in  the  cell  membrane.  Some
authors  have  associated  the  presence  of  this  toxin  with  the
development  of  severe  necrotizing  pneumonia5.
In  the  present  work  we  describe  a  case  of  necrotiz-
ing  pneumonia  with  rapid  progression  to  death  due  to
community-acquired  methicillin-resistant  S.  aureus  in  an
immunocompetent  male  patient.
On  February  2nd,  2013,  a  50-year-old  male  patient
presented  to  the  hospital  emergency  room  with  severe
headache,  bronchospasm  and  malaise.  He  had  a  history  of
hypertension  treated  with  enalapril  and  was  overweight.  He
was  then  treated  with  diclofenac,  developing  generalized
urticaria.
The  following  day  he  was  admitted  to  hospital  presenting
severe  bronchospasm  and  fever.  At  12.00  pm,  a  mild  bilat-
eral  diffuse  inﬁltrate  in  the  middle  and  lower  lung  ﬁelds  was
found  on  a  chest  X-ray.
On  admission,  laboratory  tests  revealed  a  leuko-
cyte  count  of  6300/mm3,  hematocrit  53%,  blood  glu-
cose  218  mg/dl,  urea  nitrogen  91  mg/dl  and  creatinine
2.47  mg/dl.  It  was  interpreted  as  a  respiratory  sepsis  and
ceftriaxone  and  clarithromycin  were  empirically  adminis-
tered.
In  the  following  hours  his  condition  deteriorated  rapidly.
At  5.00  pm  the  patient  was  admitted  to  intensive  care  unit
due  to  clinical  worsening  and  an  impairment  in  ventilatory
function.  He  presented  dyspnea  grade  3,  hypoventilation,
fever  and  normal  blood  pressure.  A  new  chest  X-ray  revealed
severe  bilateral  smooth  inﬁltrates  in  both  lungs.
Blood  and  urine  cultures  were  performed,  and  blood
tests  showed  leukocyte  count  3400/mm3,  urea  nitro-
c
w
S
(en  127  mg/dl,  creatinine  4.33  mg/dl,  pH:  7.195,  pCO2
2.7  mmHg,  pO2 85.7  mmHg,  CO3H− 16.2  mEq/l  and  %  SatO2
3.6.  The  Gram  stain  of  blood  specimens  showed  gram-
ositive  cocci  in  clusters.
The  patient  exhibited  a  minimal  scrotal  lesion,  and
eferred  for  a  bilateral  scrotal  inﬂammation  for  the  last
hree  days  that  was  not  evidenced  at  the  time  of  admission.
At  9.00  pm  bilateral  patched  inﬁltrates  in  both  lungs
necrotizing  pneumonia)  compatible  with  staphylococcal
nfection  were  observed  in  a  new  chest  X-ray,  whereby  a
reatment  with  vancomycin,  piperacillin/tazobactam  and
larithromycin  was  established.  Serial  chest  radiographs  are
resented  in  Fig.  1.
On  February  4th  at  1.00  am,  the  patient  remained  febrile,
liguric  and  required  mechanical  ventilation.  Laboratory
esults  at  7.00  am  were:  leukocyte  count  2000/mm3,  pH
.980,  pCO2 62.0  mmHg,  pO2 27.8  mmHg,  CO3H− 14.2  mEq/l,
 SatO2 24.7.  At  7.40  am,  the  patient  died.
Methicillin-resistant  S.  aureus  (MRSA)  grew  from  the
lood  culture.  The  strain  was  tested  for  antimicrobial
usceptibility  by  disk  diffusion  according  to  CLSI  guide-
ines,  and  showed  resistance  to  oxacillin  and  cefoxitin,
nd  susceptibility  to  erythromycin,  clindamycin,  rifampicin,
inocycline,  trimethoprim/sulfamethoxazole,  gentamicin
nd  ciproﬂoxacin.  Vancomycin  MIC  value  determined  by
test  was  1  g/ml.
Methicillin  resistance  was  conﬁrmed  through  the  ampli-
cation  of  the  mecA gene  by  the  polymerase  chain  reaction
PCR).  Detection  of  lukS/F-PV  (PVL  coding  genes)  and
CCmec  typing  were  done  by  PCR  and  the  strain  was  geno-
yped  by  pulsed  ﬁeld  gel  electrophoresis  (PFGE),  multilocus
equence  typing  (MLST)  and  spa  typing.  MRSA  was  classiﬁed
s  PFGE  type  C,  sequence  type  30,  spa  type  019,  lukS/F-PV
ositive  and  carried  SCCmecIVc. PFGE  photograph  is  shown
n  Fig.  2.
Several  cases  of  necrotizing  pneumonia  due  to  S.  aureus
ave  been  described  in  different  countries.  Even  though  it
s  a  rare  complication  of  lung  disease,  it  is  known  to  be
ggressive  and  associated  with  rapid  progression  to  death.
The  strain  recovered  in  blood  specimens  presented  a
ypical  community-acquired  phenotype  as  it  was  suscepti-
le  to  most  non-beta  lactam  antibiotics,  carried  SCCmecIV
nd  PVL  coding  genes,  conﬁrming  that  CA-MRSA  strains  are
apable  of  causing  severe  diseases  in  immunocompetent
atients.  Given  the  low  frequency  of  NP  cases,  it  could
lso  be  hypothesized  that  some  speciﬁc  host  characteristics
ould  be  necessary  to  develop  this  serious  infection.
The  prevalence  of  CA-MRSA  clones  varies  geographically,
ith  ﬁve  globally  predominant  clones:  ST1-IV  (USA400),
T8-IV  (USA300),  ST30-IV  (South  West  Paciﬁc  clone),  ST59
Taiwan  clone),  and  ST80  (European  clone).  Nowadays  ST
52  S.  Fernández  et  al.
Figure  1  Serial  chest  radiographs  from  February  
Figure  2  PFGE  pattern  of  the  strain  recovered  in  blood
specimens  and  prevalent  community  acquired  MRSA  clones  in
Argentina.  Lane  1:  MRSA  from  this  communication.  Lane  2:
CA-MRSA  clone  ST30-SCCmecIVc-spat019-PVL  positive.  Lane  3:
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Therefore,  ST30  clone  could  have  better  advantages  than
other  CA-MRSA  clones  for  developing  severe  infections;  how-A-MRSA  clone  ST5-SCCmecIVa-spat311-PVL  positive.
0  represents  one  of  the  most  frequently  isolated  lineages
mong  CA-MRSA  strains,  and  is  considered  a  pandemic  clone
s  it  has  been  isolated  repeatedly  from  every  continent9.
Clonal  complex  30  is  a  successful  S.  aureus  lineage,
rrespective  of  its  methicillin  resistance.  It  has  been  asso-
iated  with  an  increased  risk  of  infective  endocarditis10,
ncreased  hematogenous  complications3 and  persistent  S.
ureus  bacteremia15.  In  Argentina,  methicillin-sensitive  S.
ureus  (MSSA)  strains  belonging  to  the  ST30  lineage  have
e
d3rd  at  (a)  12.00  pm;  (b)  5.00  pm;  (c)  9.00  pm.
lso  been  recovered  from  cases  of  osteomyelitis  in  a  study
onducted  by  Lattar  et  al6.
Among  the  published  data  of  necrotizing  pneu-
onia  due  to  CA-MRSA,  different  clones  have  been
escribed,  e.g.  ST59-SCCmecIV-spat437-PVL  positive,
T910-SCCmecIV-spat318,  ST398-SCCmecV-spat034,  ST1409-
CCmecIV-spat6531, ST8011,  showing  that  there  would  not
e  a  unique  MRSA  clone  associated  with  this  disease,  and
ould  correspond  to  the  most  prevalent  CA-MRSA  clone  in
ach  region.  Furthermore,  we  might  be  missing  information
ue  to  the  lack  of  molecular  typing  of  S.  aureus  strains  in
ome  previous  descriptions  of  NP  cases.
It  is  not  known  if  certain  clones  have  actually  more  ability
o  cause  this  disease.  Here  we  show  that  CA-MRSA  ST30-
Vc-t019-PVL  positive  is  also  capable  of  causing  community-
cquired  necrotizing  pneumonia.
CA-MRSA  ST30-IV  belongs  to  clonal  complex  30  (CC30)
nd  is  thought  to  have  evolved  from  penicillin-resistant
hage  type  80/81  S.  aureus, a  clone  that  became  pandemic
hroughout  the  1950s  and  caused  a  high  number  of  skin
esions,  sepsis,  and  pneumonia  in  children  and  young  adults
n  hospitals  and  the  community12.
In  Argentina,  MRSA  ST30-IVc-t019-PVL  positive  has  been
escribed  as  the  most  frequent  clone  in  skin  and  soft  tis-
ues  infections  (SSTIs)  and  invasive  diseases  due  to  CA-MRSA
n  adolescent  and  adult  patients,  among  isolates  recovered
rom  two  multicenter  studies  that  included  19  hospitals
rom  Buenos  Aires  and  Santa  Fe  provinces2,7. This  clone  had
een  previously  detected  as  a  minor  clone  in  community-
ssociated  infections  in  the  eastern  and  northeastern  region
f  Argentina4, but  nowadays  it  has  replaced  the  previously
revalent  MRSA  ST5-IVa-t311-PVL  positive  clone  in  our  region
nd  is  now  apparently  well  adapted  to  the  Argentinean
ommunity2,7.
The  MRSA  clone  ST30-IVc-PVL  positive  was  also  responsi-
le  for  the  large  outbreak  in  Uruguay  in  2003  that  involved
ore  than  1000  patients  and  at  least  12  deaths8.ver,  this  approach  needs  to  be  further  investigated  in
etail.
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1Necrotizing  pneumonia  due  to  CA-MRSA  ST30-SCCmecIVc-PV
Although  community-acquired  necrotizing  pneumonia  is
often  associated  to  bad  prognosis  and  death,  there  is  also
evidence  of  good  success  of  severe  PVL  positive  S.  aureus
pneumonia  cases11,  and  the  authors  attributed  those  results
to  a  high  suspicion  of  this  pathogen  in  the  differential  diag-
nosis  that  could  lead  to  a  prompt  initiation  of  an  adequate
antimicrobial  therapy.  Therefore,  CA-MRSA  should  be  con-
sidered  in  cases  of  rapid  deterioration  of  lung  disease.
The  development  of  a  serious  infection  in  a  young  per-
son  without  predisposing  conditions  is  a  typical  feature  of
CA-MRSA  infections.  Although  in  the  case  presented  in  this
work  no  microbiological  culture  was  performed  from  the  skin
scrotal  lesion,  it  might  have  represented  the  initial  source
of  hematogenous  spread  of  CA-MRSA.  The  rapid  evolution
and  the  fatal  outcome  of  this  case  caused  by  the  preva-
lent  CA-MRSA  clone  must  be  considered  as  an  indication  of
the  invasiveness  and  virulence  potential  of  ST30-SCCmec  IVc
clone.
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